{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:41:17Z","timestamp":1793367677542,"version":"4.5.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26461206"],"award-info":[{"award-number":["26461206"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,26]]},"DOI":"10.1093\/carcin\/bgx094","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T19:11:06Z","timestamp":1504552266000},"page":"1084-1091","source":"Crossref","is-referenced-by-count":49,"title":["The genomic and epigenomic landscape in thymic carcinoma"],"prefix":"10.1093","volume":"38","author":[{"given":"Motonobu","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9975-2282","authenticated-orcid":false,"given":"Tetsuhiko","family":"Asao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"key\n\t\t\t\t20171026050840_CIT0001","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1067\/mtc.2003.133","article-title":"Aggressive multimodality treatment of invasive thymic carcinoma","volume":"125","year":"2003","journal-title":"J. Thorac. Cardiovasc. Surg"},{"key":"key\n\t\t\t\t20171026050840_CIT0002","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/era.12.29","article-title":"Chemotherapy and targeted agents for thymic malignancies","volume":"12","year":"2012","journal-title":"Expert Rev. Anticancer Ther"},{"key":"key\n\t\t\t\t20171026050840_CIT0003","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1200\/JCO.2011.36.6427","article-title":"Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma","volume":"29","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20171026050840_CIT0004","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","volume":"46","year":"2014","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20171026050840_CIT0005","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/srep07336","article-title":"Mutations of epigenetic regulatory genes are common in thymic carcinomas","volume":"4","year":"2014","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20171026050840_CIT0006","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/annonc\/mdr626","article-title":"Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors","volume":"23","year":"2012","journal-title":"Ann. Oncol"},{"key":"key\n\t\t\t\t20171026050840_CIT0007","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.lungcan.2012.08.002","article-title":"Molecular aspects of thymic carcinoma","volume":"78","year":"2012","journal-title":"Lung Cancer"},{"key":"key\n\t\t\t\t20171026050840_CIT0008","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/0008-5472.CAN-14-3282","article-title":"Development of lung adenocarcinomas with exclusive dependence on oncogene fusions","volume":"75","year":"2015","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171026050840_CIT0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","year":"2013","journal-title":"Nat. Biotechnol"},{"key":"key\n\t\t\t\t20171026050840_CIT0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","year":"2016","journal-title":"Genome Biol"},{"key":"key\n\t\t\t\t20171026050840_CIT0011","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1093\/nar\/gkr014","article-title":"GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays","volume":"39","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20171026050840_CIT0012","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/gb-2011-12-8-r72","article-title":"TopHat-Fusion: an algorithm for discovery of novel fusion transcripts","volume":"12","year":"2011","journal-title":"Genome Biol"},{"key":"key\n\t\t\t\t20171026050840_CIT0013","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nm.2644","article-title":"KIF5B-RET fusions in lung adenocarcinoma","volume":"18","year":"2012","journal-title":"Nat. Med"},{"key":"key\n\t\t\t\t20171026050840_CIT0014","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ijc.28684","article-title":"Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease","volume":"135","year":"2014","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20171026050840_CIT0015","first-page":"1202","article-title":"A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23)","volume":"63","year":"2003","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171026050840_CIT0016","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","year":"2010","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20171026050840_CIT0017","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/jcb.25047","article-title":"AHNAK2 participates in the stress-induced nonclassical FGF1 secretion pathway","volume":"116","year":"2015","journal-title":"J. Cell. Biochem"},{"key":"key\n\t\t\t\t20171026050840_CIT0018","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","year":"2013","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171026050840_CIT0019","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","year":"2015","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20171026050840_CIT0020","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","year":"2003","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20171026050840_CIT0021","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","article-title":"Thymic malignancies: from clinical management to targeted therapies","volume":"29","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20171026050840_CIT0022","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","year":"2013","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171026050840_CIT0023","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/ijc.29298","article-title":"Identification of HERC5 and its potential role in NSCLC progression","volume":"136","year":"2015","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20171026050840_CIT0024","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t20171026050840_CIT0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","article-title":"Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial","volume":"16","year":"2015","journal-title":"Lancet. Oncol"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/38\/11\/1084\/21384125\/bgx094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T12:04:28Z","timestamp":1692965068000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/carcin\/article\/38\/11\/1084\/4111255\/The-genomic-and-epigenomic-landscape-in-thymic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,9,11]]},"published-print":{"date-parts":[[2017,10,26]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgx094","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,9,11]]}}}